NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG) John (Devin) Peipert , Patricia A Baxter , Sandie Yu , Nina Oestreicher , Susan Zelt , Pablo Hernáiz Driever , Simon Bailey , Geoffrey McCowage , David S Ziegler , Olaf Witt , Hyoung Jin Kang , Timothy E Hassall , Jung Woo Han , Andrea T Franson , Michal Yalon Oren , Helen Toledano , Valérie Larouche , Mohamed S Abdelbaki , Nada Jabado , Nicholas G Gottardo , Nicolas U Gerber , Nicholas S Whipple , Devorah Segal , Susan N Chi , Liat Oren , Enrica E K Tan , Sabine Mueller , Lindsay B Kilburn , Karsten Nysom , Dong-Anh Khuong-Quang , Daniel B Landi , Jasper van der Lugt , Sarah E S Leary , Sébastien Perreault , Angela J Waanders , Darren Hargrave , Cassie Kline , Chris McKenna , Peter Manley , Sandya Govinda Raju , Jordan R Hansford Neuro-Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
